Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 549 of 5804
-
New 4-Drug cocktail aims to fight tough colorectal cancer
Disease control Recruiting nowBackground: Each year, more than 32,000 people in the United States are diagnosed with colorectal cancer that has returned or progressed after treatment and spread to other organs. This is called metastatic colorectal cancer (mCRC). Most people with mCRC survive only about 2 yea…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New hope for High-Risk blood cancer patients: givinostat faces off against standard therapy
Disease control Recruiting nowThe goal of this clinical trial is to compare the efficacy and safety of givinostat to hydroxyurea in Jak2V617F-positive high risk polycythemia vera patients.
Phase: PHASE3 • Sponsor: Italfarmaco • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Brain pacemaker for kids with cerebral palsy? new trial tests safety
Disease control Recruiting nowThe purpose of this study is to test the safety of placing Deep Brain Stimulators (DBS) in a part of the brain called the cerebellum and using electrical stimulation of that part of the brain to treat movement symptoms related to cerebral palsy. Ten children and young adults with…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New imaging technique could improve heart attack treatment outcomes
Disease control Recruiting nowThe aim of the study is to compare clinical outcomes between optical coherence tomography-guided versus angiography-guided percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI).
Phase: NA • Sponsor: Chonnam National University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Can a daily migraine pill stop attacks fast? new trial aims to find out
Symptom relief OngoingA migraine attack is a moderate or severe headache that usually occurs on one side of the head and is often accompanied by throbbing, sensitivity to light, sensitivity to sound, nausea, or other symptoms. The main goal of the study is to see if atogepant is effective, safe, and w…
Phase: PHASE3 • Sponsor: AbbVie • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
New hope for pancreatic cancer? drug combo trial shows promise
Disease control CompletedThis is a Phase 2, multicenter, open-label, 3-arm, randomized, parallel group study to evaluate the efficacy and safety of TTX-030 with or without budigalimab in combination with chemotherapy (gemcitabine + nab-paclitaxel) in subjects with metastatic PDAC who did not have prior t…
Phase: PHASE2 • Sponsor: Trishula Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug combo targets deadly thyroid cancer in small trial
Disease control Recruiting nowThis pilot phase 2 study evaluate the effectiveness and safety of pembrolizumab and lenvatinib in patients with anaplastic thyroid cancer. Patients with anaplastic thyroid cancer who are treatment-naive (BRAF-negative) and who were previously treated with chemptherapy or targeted…
Phase: PHASE2 • Sponsor: Saint Petersburg State University, Russia • Aim: Disease control
Last updated Jun 26, 2026 14:10 UTC
-
Zapping ovaries: could a quick procedure replace daily pills for PCOS infertility?
Disease control OngoingA Prospective, Multicenter, Randomized, Pivotal Study of the May Health System in Transvaginal Ablation of Ovarian Tissue under Ultrasound Guidance in Women with Infertility due to Polycystic Ovary Syndrome
Phase: NA • Sponsor: May Health • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New injection could spare cancer patients from repeated belly drains
Symptom relief OngoingA Randomized, Controlled, Multi-Center Phase III Clinical Study to Compare the Efficacy and Safety of Recombinant Anti-EpCAM and Anti-CD3 Human-Mouse Chimeric Bispecific Antibody (M701) for Intraperitoneal Injection to Paracentesis alone in Patients with Malignant Ascites Caused …
Phase: PHASE3 • Sponsor: Wuhan YZY Biopharma Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC
-
New study tests smarter dosing for newborns hooked on opioids
Symptom relief CompletedThis clinical trial will help us learn more about how to best care for babies with Neonatal Opioid Withdrawal Syndrome, also called NOWS. Babies with NOWS often have tremors, a hard time sleeping, excessive crying, and trouble feeding. Some babies that have NOWS need medicine. Do…
Phase: PHASE3 • Sponsor: HELP for NOWS Consortium • Aim: Symptom relief
Last updated Jun 27, 2026 12:34 UTC
-
New hope for Hard-to-Treat cancers: experimental PARP inhibitor enters human trials
Disease control Recruiting nowThe purpose of this study is to determine if the experimental treatment with poly-ADP ribose polymerase (PARP) inhibitor, ACE-86225106 is safe, tolerable and has anti-cancer activity in adult patients with advanced solid tumors.
Phase: PHASE1, PHASE2 • Sponsor: Acerand Therapeutics (Shanghai) Limited • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New immune cell therapy targets Hard-to-Treat cancers
Disease control Recruiting nowPhase I Study, a master protocol to investigate TCR-Engineered T cells recognizing KRAS mutations in adult subjects with Unresectable, Advanced, and/or Metastatic Solid Tumors.
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Engineered immune cells take on deadly brain tumors
Disease control TerminatedThis is a dose exploration clinical trial to assess the safety and feasibility of the IL13Ra2-targeted CAR-T in glioma.
Phase: PHASE1 • Sponsor: Yang Zhang • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New drug combo targets aggressive lymphoma in CLL patients
Disease control Recruiting nowThis is a national clinical trial, multicentric (28 centers), non-randomized phase 2 study. Population: Patients with previously untreated Richter's syndrome (RS), defined as the occurrence of an aggressive lymphoma (of diffuse large B-cell lymphoma histology) in a patient with …
Phase: PHASE2 • Sponsor: French Innovative Leukemia Organisation • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Could a single injection fix bowel leakage after childbirth? new trial aims to find out
Disease control OngoingThis study evaluates the efficacy and safety of a single injection of iltamiocel (300 x 10\^6 cells) compared to a placebo in the reduction of fecal incontinence episode frequency in adult female participants with chronic fecal incontinence and a history of obstetric anal sphinct…
Phase: PHASE3 • Sponsor: Cook MyoSite • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Could 3 weeks of proton therapy be as safe as 5 for breast cancer?
Disease control Recruiting nowThe purpose of this research study is to learn more about the effects of using proton radiation therapy delivered over a shorter course of treatment (3 weeks) compared with a longer, standard course of treatment (5 weeks) for women with breast cancer who require radiotherapy to t…
Phase: PHASE3 • Sponsor: Proton Collaborative Group • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New hope for head and neck cancer: drug may prevent recurrence after chemoradiation
Disease control Recruiting nowThe goal of this study is to assess the safety and effectiveness of Dostarlimab compared to Placebo in adult participants with Head and Neck Squamous Cell Carcinoma (HNSCC)
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Could a single shot before surgery shield your heart?
Prevention Recruiting nowThis is an investigator initiated, multi-center, open-labelled, superiority randomized controlled trial of 372 patients undergoing elective non-cardiac surgery. Recruited patients will be randomized in a 2:1 ratio to receive single subcutaneous dose of Glucagon-like Peptide-1 Rec…
Phase: PHASE4 • Sponsor: The University of Hong Kong • Aim: Prevention
Last updated Jun 27, 2026 12:29 UTC
-
Laser resurfacing may shield aging skin from cancer
Prevention Recruiting nowThe purpose of this study is to determine if the Fractionated Laser Resurfacing (FLR) procedure can protect one forearm/wrist from precancerous actinic keratosis (AKs) as well as prevent skin cancer in older subjects with active AKs. This study builds on a similar study ongoing a…
Phase: NA • Sponsor: Wright State University • Aim: Prevention
Last updated Jul 18, 2026 00:00 UTC
-
Can a simple text message keep opioid patients on track?
Disease control OngoingThere is growing recognition of the need for approaches to initiate treatment wherever patients touch the health care system, including the Emergency Department (ED). Most research has focused on initiation of medications for opioid use disorder (MOUDs) in the ED rather than ensu…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC